Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene

This publication has 14 references indexed in Scilit:

• Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity
  Carcinogenesis: Integrative Cancer Research, 1987
• Sulfation of N-hydroxy-2-acetylaminofluorene in Normal and Nodular Liver from Male Wistar Rats
  Toxicologic Pathology, 1987
• Effect of sulfotransferase inhibitors on the 2-acetylaminofluorene-mediated lowering of rat liver N-hydroxy-2-acetylaminofluorene sulfotransferase activity
  Biochemical Pharmacology, 1985
• N-Sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J × C3H/HeJ F₁ (B6C3F₁) mice
  Carcinogenesis: Integrative Cancer Research, 1985
• Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: the role of N,O-sulfonation in chemical carcinogenesis of aromatic amines.
  Environmental Health Perspectives, 1983
• Rapid decrease in N-hydroxy-2-acetylaminofluorene sulfotransferase activity of liver cytosols from rats fed carcinogen
  Biochemical Pharmacology, 1983
• Sulfotransferase and deacetylase in normal and tumor-bearing liver of CD rats: autoradiographical studies with N-hydroxy-2-acetylamino-fluorene and N-hydroxy-4-acetylaminobiphenyl in vitro andin vivo
  Carcinogenesis: Integrative Cancer Research, 1982
• Prevention of the hepatotoxic action of N-hydroxy-2-acetylaminofluorene in the rat by inhibition of NO-sulfation by pentachlorophenol
  Life Sciences, 1981
• Generation of reactive metabolites of N-hydroxy-phenacetin by glucuronidation and sulfation
  Biochemical Pharmacology, 1977
• Enzyme-Catalyzed Reactions of the Carcinogen N -Hydroxy-2-fluorenylacetamide with Nucleic Acid
  Science, 1968